HUP0303534A3 - Modified interferon beta with reduced immunogenicity - Google Patents

Modified interferon beta with reduced immunogenicity

Info

Publication number: HUP0303534A3
Authority: HU; Hungary
Prior art keywords: interferon beta; reduced immunogenicity; modified interferon; modified; immunogenicity
Prior art date: 2001-03-15

Application number

HU0303534A

Other languages

English (en)

Original Assignee

Merck Patent Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-15

Filing date

2002-03-15

Publication date

2005-12-28

2002-03-15 Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh

2004-01-28 Publication of HUP0303534A2 publication Critical patent/HUP0303534A2/hu

2005-12-28 Publication of HUP0303534A3 publication Critical patent/HUP0303534A3/hu

Links

102000003996 Interferon-beta Human genes 0.000 title 1
108090000467 Interferon-beta Proteins 0.000 title 1
230000005847 immunogenicity Effects 0.000 title 1
229960001388 interferon-beta Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/565—IFN-beta
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Zoology (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

HU0303534A 2001-03-15 2002-03-15 Modified interferon beta with reduced immunogenicity HUP0303534A3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP01106539		2001-03-15
PCT/EP2002/002925 WO2002074783A2 (en)	2001-03-15	2002-03-15	Modified interferon beta with reduced immunogenicity

Publications (2)

Publication Number	Publication Date
HUP0303534A2 HUP0303534A2 (hu)	2004-01-28
HUP0303534A3 true HUP0303534A3 (en)	2005-12-28

Family

ID=8176796

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU0303534A HUP0303534A3 (en)	2001-03-15	2002-03-15	Modified interferon beta with reduced immunogenicity

Country Status (13)

Country	Link
US (2)	US7381795B2 (hu)
EP (1)	EP1368377A2 (hu)
JP (1)	JP2004529633A (hu)
KR (1)	KR20030084992A (hu)
CN (1)	CN1496369A (hu)
BR (1)	BR0208041A (hu)
CA (1)	CA2441095A1 (hu)
HU (1)	HUP0303534A3 (hu)
MX (1)	MXPA03008310A (hu)
PL (1)	PL362870A1 (hu)
RU (1)	RU2003129072A (hu)
WO (1)	WO2002074783A2 (hu)
ZA (1)	ZA200307992B (hu)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7381795B2 (en) *	2001-03-15	2008-06-03	Merck Patent Gmbh	Modified interferon beta with reduced immunogenicity
US20030198624A1 (en) *	2002-03-02	2003-10-23	Mohapatra Shyam S.	Method of treating allergic disease and asthma by recombinant adenovirus- and adeno-associated virus- mediated IFN-gamma gene transfer
CA2484251C (en) *	2002-04-30	2015-06-23	University Of South Florida	Materials and methods for inhibition of respiratory syncytial virus infection
DE60332556D1 (de) *	2002-05-01	2010-06-24	Danisco Us Inc	Cytokine und cytokinrezeptoren mit reduzierter immunogenität
US7595303B1 (en)	2002-09-05	2009-09-29	University Of South Florida	Genetic adjuvants for immunotherapy
DE60332358D1 (de) *	2002-09-09	2010-06-10	Hanall Pharmaceutical Co Ltd	Protease-resistente modifizierte interferon alpha polypeptide
CA2516188C (en) *	2003-02-14	2012-04-17	University Of South Florida	Chitosan-derivatives for gene delivery and expression
WO2005003157A2 (en) *	2003-06-10	2005-01-13	Xencor, Inc.	Interferon variants with improved properties
US20050266093A1 (en) *	2004-04-27	2005-12-01	Mohapatra Shyam S	Nanogene therapy for cell proliferation disorders
US7670595B2 (en) *	2004-06-28	2010-03-02	Merck Patent Gmbh	Fc-interferon-beta fusion proteins
US20080038224A1 (en) *	2006-03-28	2008-02-14	Thierry Guyon	Modified interferon-beta (IFN-beta) polypeptides
EP2423221B1 (en)	2007-01-30	2015-04-29	Epivax, Inc.	Regulatory t cell epitopes, compositions and uses thereof
CN103965347B (zh)	2007-05-02	2017-07-18	Ambrx公司	经修饰干扰素β多肽和其用途
US20090010966A1 (en) *	2007-06-21	2009-01-08	Angelica Therapeutics, Inc.	Modified diphtheria toxins
EP2268297A4 (en) *	2008-02-29	2011-11-16	Angelica Therapeutics Inc	MODIFIED TOXINS
MX2011011044A (es)	2009-04-22	2011-11-04	Merck Patent Gmbh	Proteinas de fusion de anticuerpos con sitios de enlace de receptor fc neonatal (fcrn) modificados.
IN2014CN02982A (hu)	2011-10-01	2015-07-03	Glytech Inc
US10059750B2 (en)	2013-03-15	2018-08-28	Angelica Therapeutics, Inc.	Modified toxins
BR112015024423B1 (pt)	2013-03-29	2023-04-25	Glytech, Inc	Polipeptídeo glicosilado tendo atividade de interferon ?, composição farmacêutica e uso de um polipeptídeo glicosilado

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4737462A (en) *	1982-10-19	1988-04-12	Cetus Corporation	Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
GB8317880D0 (en) *	1983-07-01	1983-08-03	Searle & Co	Structure and synthesis of interferons
ES2258817T3 (es) *	1997-05-21	2006-09-01	Biovation Limited	Metodo para la produccion de proteinas no inmunogenas.
BR9915548A (pt) *	1998-10-16	2001-08-14	Biogen Inc	Proteìnas de fusão de interferon-beta e usos
EP1051432B1 (en) *	1998-12-08	2007-01-24	Biovation Limited	Method for reducing immunogenicity of proteins
US6514729B1 (en) *	1999-05-12	2003-02-04	Xencor, Inc.	Recombinant interferon-beta muteins
US6531122B1 (en) *	1999-08-27	2003-03-11	Maxygen Aps	Interferon-β variants and conjugates
US7381795B2 (en) *	2001-03-15	2008-06-03	Merck Patent Gmbh	Modified interferon beta with reduced immunogenicity

2002
- 2002-03-15 US US10/471,894 patent/US7381795B2/en not_active Expired - Fee Related
- 2002-03-15 CN CNA028065972A patent/CN1496369A/zh active Pending
- 2002-03-15 EP EP02726180A patent/EP1368377A2/en not_active Withdrawn
- 2002-03-15 BR BR0208041-9A patent/BR0208041A/pt not_active IP Right Cessation
- 2002-03-15 MX MXPA03008310A patent/MXPA03008310A/es unknown
- 2002-03-15 RU RU2003129072/13A patent/RU2003129072A/ru not_active Application Discontinuation
- 2002-03-15 KR KR10-2003-7011997A patent/KR20030084992A/ko not_active Application Discontinuation
- 2002-03-15 CA CA002441095A patent/CA2441095A1/en not_active Abandoned
- 2002-03-15 HU HU0303534A patent/HUP0303534A3/hu unknown
- 2002-03-15 WO PCT/EP2002/002925 patent/WO2002074783A2/en active Application Filing
- 2002-03-15 JP JP2002573792A patent/JP2004529633A/ja active Pending
- 2002-03-15 PL PL02362870A patent/PL362870A1/xx unknown
2003
- 2003-10-14 ZA ZA200307992A patent/ZA200307992B/en unknown
2008
- 2008-03-17 US US12/077,120 patent/US7615615B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
WO2002074783A2 (en)	2002-09-26
ZA200307992B (en)	2005-01-14
BR0208041A (pt)	2004-02-25
HUP0303534A2 (hu)	2004-01-28
EP1368377A2 (en)	2003-12-10
KR20030084992A (ko)	2003-11-01
CN1496369A (zh)	2004-05-12
MXPA03008310A (es)	2003-12-11
RU2003129072A (ru)	2005-04-20
US7615615B2 (en)	2009-11-10
US20050054052A1 (en)	2005-03-10
US20090043076A1 (en)	2009-02-12
JP2004529633A (ja)	2004-09-30
CA2441095A1 (en)	2002-09-26
WO2002074783A3 (en)	2003-08-28
US7381795B2 (en)	2008-06-03
PL362870A1 (en)	2004-11-02

Legal Events

Date	Code	Title	Description
2006-09-28	FA9A	Lapse of provisional patent protection due to relinquishment or protection considered relinquished

Publication	Publication Date	Title
GB0118651D0 (en)	2001-09-19	Flat-plate
HUP0303534A3 (en)	2005-12-28	Modified interferon beta with reduced immunogenicity
PT1361893E (pt)	2013-01-24	Anticorpos anti-rfce modificados com imunogenicidade reduzida
MXPA03007323A (es)	2003-12-12	Proteinas artificiales con inmunogenicidad reducida.
GB9912350D0 (en)	1999-07-28	Modified cytokine
GB0130645D0 (en)	2002-02-06	Cellectivity technology overview
HUP0402259A3 (en)	2010-01-28	Vaccines
GB2391571B (en)	2005-05-11	Sintered wellscreen
EP1581631A4 (en)	2007-09-05	INTERFERON VARIANTS HAVING IMPROVED PROPERTIES
PL363181A1 (en)	2004-11-15	Modified interferon alpha with reduced immunogenicity
PL362375A1 (en)	2004-10-18	Modified leptin with reduced immunogenicity
GB2393372B (en)	2005-08-31	Multi-power heaters
HUP0303430A3 (en)	2005-11-28	Modified protamine with reduced immunogenicity
PL372202A1 (en)	2005-07-11	Modified byrodin 1 with reduced immunogenicity
HUP0401121A3 (en)	2006-01-30	Modified thrombopoietin with reduced immunogenicity
HUP0303523A3 (en)	2005-12-28	Modified insulin with reduced immunogenicity
GB0105238D0 (en)	2001-04-18	Vaccines
AU2003276846A8 (en)	2004-02-25	Thrombopoiesis-stimulating proteins having reduced immunogenicity
GB2383044B (en)	2006-06-14	Alstroem syndrome gene
GB2372248B (en)	2003-12-24	Kiln furniture
GB2412555B (en)	2006-01-11	Multi-power heaters
TW538729U (en)	2003-06-21	Chair with heating function
GB0130194D0 (en)	2002-02-06	Jetlift with downward thrust
MXPA03008086A (es)	2003-12-12	Protamina modificada con inmunogenicidad reducida.
GB0118684D0 (en)	2001-09-19	Sun rise